Researchers are developing diagnostics to determine which drugs might work for specific patients
Memorial Sloan Kettering researchers are building a safer opioid
The medication can reduce the duration of symptoms
Survival was better than expected with this genetically modified pathogen
The drug will treat two rare forms of epilepsy
Many Earth-bound efforts focus on synthetic chemicals, but some researchers hope the stress of space could provide new insights
No new cases have been reported for two weeks in the Democratic Republic of the Congo
At the second Science on the Hill event, AI, Robotics and Your Health, experts from academia and the private sector talked with Scientific American Editor in Chief Mariette DiChristina about the future of AI and robotics in medicine.
Right now, each child would need to be tested prior to receiving the shot
This new cell-sorting method could offer more options in the lab and clinic
Rapid-response therapies use the lethal bug’s own speed to crowd it out of the gut
Only one experimental shot, made by Merck, has been approved for use amid the current outbreak
The canine clinical trial will vaccinate 800 healthy pets
For 200 years, the USP, founded as United States Pharmacopeia, has been working behind the scenes to help ensure that medicines are what they claim. What’s next for one of the most important standards-setting organizations that you’ve never heard of?
The final decision about which potential therapies to allow rests with the DRC government
Pediatric cardiologist Ismée Williams discusses her young adult novel, Water in May, about a teenage girl whose newborn has a life-threatening heart condition.
The agency’s first target will be hemophilia
Cancer treatment using the notorious drug may hold promise for other diseases like Alzheimer’s
The state is the first to approve such legislation, but importation would still require federal sign-off
Clinical trial patients had two fewer headaches a month compared with those who received a placebo